三力制药
(603439)
| 流通市值：54.44亿 | | | 总市值：54.44亿 |
| 流通股本：4.04亿 | | | 总股本：4.04亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 559,317,019.11 | 381,730,286.64 | 1,702,842,901.68 | 1,038,498,412.06 |
| 营业收入 | 559,317,019.11 | 381,730,286.64 | 1,702,842,901.68 | 1,038,498,412.06 |
| 二、营业总成本 | 525,579,978.41 | 327,451,779.8 | 1,521,731,029.37 | 964,371,007.43 |
| 营业成本 | 160,868,443.17 | 107,775,843.37 | 511,485,032.02 | 325,518,798.86 |
| 税金及附加 | 7,216,127.33 | 5,608,871.35 | 26,810,396.57 | 14,226,070.1 |
| 销售费用 | 296,815,911.67 | 184,913,299.04 | 800,918,155.93 | 486,860,718.56 |
| 管理费用 | 45,169,885.72 | 22,326,775.73 | 147,384,803.38 | 113,041,719.36 |
| 研发费用 | 6,683,857.23 | 2,374,005.84 | 27,913,455.39 | 19,391,017.47 |
| 财务费用 | 8,825,753.29 | 4,452,984.47 | 7,219,186.08 | 5,332,683.08 |
| 其中:利息费用 | 9,391,256.81 | 4,677,119.68 | 11,074,230.19 | 7,159,495.15 |
| 其中:利息收入 | 574,655.21 | 687,918.08 | 3,958,428.09 | 1,882,555.43 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 6,475.6 | 38,193.6 | 155,822.2 | 199,659.21 |
| 加:投资收益 | 651,292.63 | -33,709.78 | -2,772,299.71 | -3,187,150.12 |
| 资产处置收益 | 309,851.44 | 1,214.46 | -115,565.58 | 92,041.7 |
| 资产减值损失(新) | -2,732,353.41 | - | -129,825,096.73 | -1,710,772.88 |
| 信用减值损失(新) | 3,389,181.99 | -5,287,786.69 | 5,627,069.87 | 8,878,739.62 |
| 其他收益 | 9,468,894.51 | 2,502,133.86 | 10,364,359.65 | 7,567,289.56 |
| 四、营业利润 | 44,830,383.46 | 51,498,552.29 | 64,546,162.01 | 85,967,211.72 |
| 加:营业外收入 | 16,716.11 | 16,616.11 | 6,921,263.34 | 6,872,222.38 |
| 减:营业外支出 | 1,118,161.14 | 89,163.16 | 3,701,971.05 | 185,996.67 |
| 五、利润总额 | 43,728,938.43 | 51,426,005.24 | 67,765,454.3 | 92,653,437.43 |
| 减:所得税费用 | 5,938,150.51 | 6,288,089.73 | 19,611,851.56 | 8,976,120.2 |
| 六、净利润 | 37,790,787.92 | 45,137,915.51 | 48,153,602.74 | 83,677,317.23 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 37,790,787.92 | 45,137,915.51 | 48,153,602.74 | 83,677,317.23 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 37,180,955.21 | 44,411,545.94 | 46,254,223.69 | 80,786,973.31 |
| 少数股东损益 | 609,832.71 | 726,369.57 | 1,899,379.05 | 2,890,343.92 |
| 扣除非经常损益后的净利润 | 42,229,041.98 | 43,263,720.03 | 26,322,288.36 | 66,428,551.43 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.09 | 0.11 | 0.11 | 0.2 |
| (二)稀释每股收益 | 0.09 | 0.11 | 0.11 | 0.2 |
| 九、综合收益总额 | 37,790,787.92 | 45,137,915.51 | 48,153,602.74 | 83,677,317.23 |
| 归属于母公司股东的综合收益总额 | 37,180,955.21 | 44,411,545.94 | 46,254,223.69 | 80,786,973.31 |
| 归属于少数股东的综合收益总额 | 609,832.71 | 726,369.57 | 1,899,379.05 | 2,890,343.92 |
| 公告日期 | 2026-08-28 | 2026-04-27 | 2026-04-27 | 2025-10-28 |
| 审计意见(境内) | | | 标准无保留意见 | |